Johannes Gutenberg-Universität Mainz
Saarstr. 21, 55099 Mainz
- 6131/39-0
Forschungsprojekte
Ergebnisse pro Seite:
10
2022 - 2040
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera (#1418)- Prof. Dr. MarkusRadsak
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. MaximilianBrandt,
- PD Dr. ReneMager,
- Dr. AnitaThomas
2022 - 2025
Kompatibilität und Stabilität von applikationsfertigen Parenteralia- Prof. Dr. IreneKrämer,
- ZoeMittmann,
- Dr. JudithThiesen
2022 - 2027
Analysis of antibody responses against tumor-derived neo-antigens in triple-negative breast cancer (TNBC)- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Anne-SophieHeimes
2022 - 2027
Characterization of the immunoglobulin repertoire of tumor-infiltrating plasma cells and correlation of factors within the plasma with prognosis in early breast cancer- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Anne-SophieHeimes
2022 - 2027
Isolation and characterization of tumor stem cells utilizing ascites or pleural effusions- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Anne-SophieHeimes
2022 - 2029
Process optimization for the identification of patient-specific neo-antigens in breast cancer patients- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Anne-SophieHeimes
2022 - 2029
Concordance of biomarkers between primary breast tumors and matched distant metastases- Univ.-Prof. Dr. MarcusSchmidt,
- Dr. KathrinStewen,
- PD Dr. KatrinAlmstedt
2022 - 2027
Prognostic role of LAG-3 in early breast cancer- Univ.-Prof. Dr. MarcusSchmidt,
- PD Dr. Anne-SophieHeimes